Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-26-026792
Filing Date
2026-08-10
Accepted
2026-08-10 16:37:06
Documents
69
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20260630_10q.htm   iXBRL 10-Q 862038
2 EXHIBIT 10.1 ex_1001529.htm EX-10.1 201507
3 EXHIBIT 31.1 ex_995812.htm EX-31.1 12618
4 EXHIBIT 31.2 ex_995813.htm EX-31.2 12702
5 EXHIBIT 32.1 ex_995814.htm EX-32.1 4679
6 EXHIBIT 32.2 ex_995815.htm EX-32.2 4745
12 fig01.jpg GRAPHIC 110119
13 logolarge.jpg GRAPHIC 20286
  Complete submission text file 0001437749-26-026792.txt   5315724

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA dmac-20260630.xsd EX-101.SCH 45607
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20260630_def.xml EX-101.DEF 294628
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20260630_lab.xml EX-101.LAB 240299
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20260630_pre.xml EX-101.PRE 324780
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20260630_cal.xml EX-101.CAL 33575
73 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20260630_10q_htm.xml XML 690253
Mailing Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305
Business Address 301 CARLSON PARKWAY SUITE 210 MINNEAPOLIS MN 55305 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 261259055
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)